|
SEGMENT INFORMATION - Profitability (Details) (USD $)
In Millions, unless otherwise specified |
3 Months Ended | |
|---|---|---|
|
Jan. 31, 2015
|
Jan. 31, 2014
|
|
| Segment Reporting [Abstract] | ||
| Number of operating segments | 3 | |
| Select Income Statement Components | ||
| Total net revenue | $ 1,026 | $ 1,008 |
| Income from operations | 115 | 124 |
| Life Sciences and Applied Markets | ||
| Select Income Statement Components | ||
| Total net revenue | 547 | 537 |
| Income from operations | 107 | 105 |
| Diagnostics and Genomics | ||
| Select Income Statement Components | ||
| Total net revenue | 148 | 157 |
| Income from operations | 1 | 19 |
| Agilent CrossLab | ||
| Select Income Statement Components | ||
| Total net revenue | 331 | 314 |
| Income from operations | 68 | 69 |
| Segment Total | ||
| Select Income Statement Components | ||
| Total net revenue | 1,026 | 1,008 |
| Income from operations | $ 176 | $ 193 |